Literature DB >> 1573420

Changing patterns of glucose metabolism during the course of subacute sclerosing panencephalitis as measured with 18FDG-positron-emission tomography.

M Huber1, G Pawlik, S Bamborschke, G R Fink, H Karbe, M Schlenker, H Bewermeyer, W D Heiss.   

Abstract

18FDG-positron emission tomography performed at different stages in the course of subacute sclerosing panencephalitis revealed a changing pattern of metabolic disturbance. In clinical stage II patients the inflammation in the basal ganglia appeared to lead to neuronal excitation accompanied by hypermetabolism. Widespread cortical functional inhibition of metabolism followed. The striatal inflammation ended with necrosis and hypometabolism, with resulting functional cortical disinhibition; later, deep midbrain structures and brain stem became hypermetabolic. A patient clinically in remission showed no such changes in cerebral glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1573420     DOI: 10.1007/bf00833917

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

Review 1.  Statistical analysis of functional neuroimaging data: exploratory versus inferential methods.

Authors:  G Pawlik
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

Review 2.  Subacute sclerosing panencephalitis. Current status.

Authors:  P R Dyken
Journal:  Neurol Clin       Date:  1985-02       Impact factor: 3.806

3.  Cerebrospinal fluid virus antibodies. A diagnostic indicator for multiple sclerosis?

Authors:  K Felgenhauer; H J Schädlich; M Nekic; R Ackermann
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

4.  Subacute sclerosing panencephalitis. Correlation of clinical, neurophysiologic and neuropathologic findings.

Authors:  T Oya; A J Martinez; J T Jabbour; H Lemmi; D A Duenas
Journal:  Neurology       Date:  1974-03       Impact factor: 9.910

5.  Estimation of local cerebral glucose utilization by positron emission tomography of [18F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures.

Authors:  K Wienhard; G Pawlik; K Herholz; R Wagner; W D Heiss
Journal:  J Cereb Blood Flow Metab       Date:  1985-03       Impact factor: 6.200

6.  Signs of focal posterior cerebral abnormality in early subacute sclerosing panencephalitis.

Authors:  J H Begeer; R Haaxma; J W Snoek; S Boonstra; R le Coultre
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

Review 7.  Notes on the pathogenesis of subacute sclerosing panencephalitis.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1990-02       Impact factor: 3.181

8.  Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.

Authors:  W D Heiss; G Pawlik; K Herholz; R Wagner; H Göldner; K Wienhard
Journal:  J Cereb Blood Flow Metab       Date:  1984-06       Impact factor: 6.200

9.  Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography.

Authors:  K Yanai; K Iinuma; T Matsuzawa; M Ito; S Miyabayashi; K Narisawa; T Ido; K Yamada; K Tada
Journal:  Eur J Nucl Med       Date:  1987

10.  Detection and identification of virus-specific, oligoclonal IgG in unconcentrated cerebrospinal fluid by immunoblot technique.

Authors:  R Dörries; V Ter Meulen
Journal:  J Neuroimmunol       Date:  1984-12       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.